Monday November 21

Pia Steensland

Institutionen för klinisk neurovetenskap, Karolinska Institutet, Sweden

Associate Professor Pia Steensland defended her thesis ““Anabolic Androgenic Steroids and the Brain – Studies of Neurochemical and Behavioural Changes Using an Animal Model” under the supervision of Professor Fred Nyberg at Uppsala University, Faculty of Pharmacy in 2002. After a successful postdoc at Ernest Gallo Clinic and Research Center, University of California San Francisco, Dr Steensland was recruited to Karolinska Institutet in 2008. Based on her wide methodological background within behavioral psychopharmacology, she established an Experimental Addiction Research Platform with the aim to increase the understanding of the underlying mechanisms in the brain during the development and maintenance of alcohol use disorder, and the ultimate goal to identify potential novel effective medications.

Dopamine – revisited as a potential treatment target for alcohol dependence

Alcohol use disorder (AUD) is associated with a dysregulated dopamine system modulating e.g. reward, craving and impulsivity. The monoamine stabilizer (-)-OSU6162 (OSU6162; developed by Nobel Laureate Arvid Carlsson) is suggested to attenuate or stimulate dopamine functioning depending on the prevailing dopaminergic tone and thus has potential as a novel AUD medication. We recently showed that OSU6162 attenuates several alcohol-mediated behaviors in long-term drinking rats. In addition, our placebo-controlled human laboratory study showed that OSU6162 significantly attenuates craving and the subjective “liking” of the consumed alcohol in AUD patients. An effect driven by individuals with higher baseline impulsivity. Furthermore, our animal studies showed that OSU6162 improves impulse control as and restores dopamine deficits in the Nucleus Accumbens induced by long-term voluntary alcohol consumption. In conclusion, together with OSU6162’s favorable side effect profile, these results merit further evaluation of the effect of OSU6162 on alcohol use outcomes in alcohol dependent patients.

Read more about Pia Steenslands research

Host: Maria Papathanou

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Ok!Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT